Tag Archives: Myriad

Federal Circuit Opinion On Myriad Remand

Posted on August 16, 2012 by Warren Woessner

Today, the Federal Circuit issued its opinion following GVR from the Supreme Court in AMP v. USPTO and Myriad Genetics, Inc., App. No. 2010-1406 (August 16,2012). (A copy of the opinion is available at the end of this post.) Unfortunately, … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , | 1 Comment

Why Myriad Should Drop Its Appeal

Posted on July 16, 2012 by Warren Woessner

In the Kenny Rogers song, “The Gambler,” Rogers sings “You got to know when to hold ‘em, know when to fold ‘em.” There is still time for Myriad to “fold ‘em” and drop its appeal of the district court decision … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 2 Comments

“In Leukemia Treatment, Glimpses of the Future” of Medicine and IP

Posted on July 9, 2012 by Warren Woessner

A provocative article in the Sunday New York Times recounted how a young cancer researcher, who was diagnosed with acute lymphoblastic leukemia (ALL), and who responded but relapsed twice after receiving chemotherapy and bone marrow transplant, achieved a third remission … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment

Lilly Files Amicus Brief in Myriad Remand – With Friends Like This…

Posted on June 26, 2012 by Warren Woessner

Following its reversal of the Fed. Cir.’s decision in Mayo v. Prometheus (“Mayo”), the Supreme Court GVR’d in response to AMP’s (read: ACLU’s) appeal of Myriad’s claims to isolated DNA sequences and to a method of screening potential anti-cancer drugs … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | Leave a comment